Reduced liver damage and fibrosis with combined SCD Probiotics and intermittent fasting in aged rat

dc.authoridCeylani, Taha/0000-0002-3041-6010
dc.authoridBaba, Burcu/0000-0003-0994-3577
dc.authoridKESKIN, SEDA/0000-0002-4726-982X
dc.contributor.authorTeker, Hikmet Taner
dc.contributor.authorCeylani, Taha
dc.contributor.authorKeskin, Seda
dc.contributor.authorSamgane, Gizem
dc.contributor.authorBaba, Burcu
dc.contributor.authorAcikgoz, Eda
dc.contributor.authorGurbanov, Rafig
dc.date.accessioned2025-05-20T18:56:14Z
dc.date.issued2024
dc.departmentBilecik Şeyh Edebali Üniversitesi
dc.description.abstractThis study aimed to examine the impact of SCD Probiotics supplementation on liver biomolecule content and histological changes during a 30-day intermittent fasting (IF) program in 24-month-old male Sprague-Dawley rats. Rats underwent 18-h daily fasting and received 1 x 10(8) CFU of SCD Probiotics daily. Liver tissue biomolecules were analysed using FTIR Spectroscopy, LDA, and SVM techniques, while histopathological evaluations used Haematoxylin and eosin and Masson trichrome-stained tissues. Blood samples were collected for biochemical analysis. Gross alterations in the quantity of biomolecules were observed with individual or combined treatments. LDA and SVM analyses demonstrated a high accuracy in differentiating control and treated groups. The combination treatments led to the most significant reduction in cholesterol ester (1740 cm(-1)) and improved protein phosphorylation (A(1239)/A(2955) and A(1080)/A(1545)) and carbonylation (A(1740)/A(1545)). Individually, IF and SCD Probiotics were more effective in enhancing membrane dynamics (Bw(2922)/Bw(2955)). In treated groups, histological evaluations showed decreased hepatocyte degeneration, lymphocyticinfiltration, steatosis and fibrosis. Serum ALP, LDH and albumin levels significantly increased in the SCD Probiotics and combined treatment groups. This study offers valuable insights into the potential mechanisms behind the beneficial effects of IF and SCD Probiotics on liver biomolecule content, contributing to the development of personalized nutrition and health strategies.
dc.identifier.doi10.1111/jcmm.18014
dc.identifier.issn1582-1838
dc.identifier.issn1582-4934
dc.identifier.issue1
dc.identifier.pmid37897241
dc.identifier.scopus2-s2.0-85175354383
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1111/jcmm.18014
dc.identifier.urihttps://hdl.handle.net/11552/7640
dc.identifier.volume28
dc.identifier.wosWOS:001092103800001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWoS
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.indekslendigikaynakWoS - Science Citation Index Expanded
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofJournal of Cellular and Molecular Medicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250518
dc.subjectfibrosis
dc.subjectFTIR
dc.subjectintermittent fasting
dc.subjectliver
dc.subjectrat
dc.subjectSCD probiotics
dc.titleReduced liver damage and fibrosis with combined SCD Probiotics and intermittent fasting in aged rat
dc.typeArticle

Dosyalar